Dr Rovel Colaco



After completing his training as a specialist registrar in Clinical Oncology at The Christie NHS Foundation Trust, Dr Colaco was selected as the first UK doctor to train in proton therapy spending 12 months working at the University of Florida Proton Therapy Institute in Jacksonville, Florida.

He was subsequently the first graduate of the Stereotactic Radiosurgery and Radiotherapy program at Yale University in Connecticut, USA. While there, he worked with a variety of radiotherapy delivery platforms including the Cyberknife, Gammaknife and Novalis TX treating patients with stereotactic radiosurgery (SRS) for brain metastases and stereotactic ablative radiotherapy (SABR), for both primary lung tumours and oligo-metastatic disease from other primary cancer sites.

Following his return from the United States, he was appointed as a consultant clinical oncologist at The Christie where he specialises in the treatment of adult brain tumours and paediatric tumours along with stereotactic radiotherapy for brain metastases and oligo-metastases.

He also sees patients for proton therapy and is involved in the development of The Christie proton beam centre and in trust’s program for oligo-metastatic disease including treating tumours which have metastasised to bone, spine and lymph nodes with SABR.

Consultant Details

  • Consulting Address
    The Christie Private Care, Wilmslow Road, Manchester M20 4BX
  • NHS Base
    The Christie NHS Foundation Trust
  • Qualifications
    BsC Hons, MB ChB, MRCP, FRCR
  • Research Interest
    Proton therapy, stereotactic radiotherapy and CNS tumours. Dr Colaco has presented at international conferences and published several papers on the use of proton therapy and stereotactic radiotherapy for a variety of cancer sites. He is the principal investigator at The Christie NHS Foundation Trust for the CORE trial which is examining the role of stereotactic radiotherapy in oligo-metastatic breast, lung and prostate cancers.
  • Speciality
    Brain tumours, bone cancer, lymph node cancer and spinal cord tumours
  • Sub Speciality
    Primary brain tumours, metastatic brain tumours, stereotactic radiotherapy, oligo-metastases, proton therapy
  • Contact details for appointments

    Please contact your consultants secretary, or the patient liaison team, on 0161 918 7296
    Or Email - info.christieclinic@hcahealthcare.co.uk
    Or Fax to - 0161 446 8027